Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Meanwhile, BioNTech and its AI subsidiary InstaDeep introduced an AI assistant named Laila, built on Meta's Llama 3.1 model. During a live demonstration, research scientist Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab assistants aimed at enhancing scientific research.
Alphabet Inc.（纳斯达克股票代码：GOOG）（纳斯达克股票代码：GOOG）旗下的谷歌DeepMind和BioNTech（纳斯达克股票代码：BNTX）正在合作开发旨在加强科学研究的人工智能实验室助手。
What Happened: Sir Demis Hassabis, head of Google's AI division, is spearheading the creation of an AI model designed to function as a research assistant. This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research, Financial Times reported on Wednesday.
发生了什么：谷歌人工智能部门负责人戴米斯·哈萨比斯爵士正在带头创建一种旨在充当研究助理的人工智能模型。《金融时报》周三报道，这种人工智能旨在促进跨学科合作并发现科学研究中的意想不到的联系。
At a recent Nobel Foundation event, Hassabis highlighted the transformative impact of AI on biology, stating, "We're working on a science large language model that could be like a research assistant and maybe help you predict the outcome of an experiment."
在最近的一次诺贝尔基金会活动中，哈萨比斯强调了人工智能对生物学的变革性影响，他说：“我们正在研究一种大型科学语言模型，它可以像研究助理一样，可以帮助你预测实验的结果。”
Meanwhile, BioNTech and its AI subsidiary InstaDeep introduced an AI assistant named Laila, built on Meta's Llama 3.1 model. During a live demonstration, research scientist Arnu Pretorius showcased Laila's capabilities in automating routine tasks in experimental biology.
同时，BioNTech及其人工智能子公司InstaDeep推出了一款名为Laila的人工智能助手，该助手基于Meta的Llama 3.1模型构建。在现场演示中，研究科学家阿努·普雷托里乌斯展示了莱拉在实验生物学中自动化常规任务的能力。
InstaDeep's CEO Karim Beguir emphasized that AI agents like Laila are intended to boost productivity, allowing scientists to focus on critical tasks. The AI models presented by InstaDeep also aim to assist BioNTech in identifying new targets for cancer treatment.
InstaDeep的首席执行官卡里姆·贝吉尔强调，像莱拉这样的人工智能代理旨在提高生产力，使科学家能够专注于关键任务。InstaDeep提出的人工智能模型还旨在帮助BioNTech确定癌症治疗的新靶标。
Why It Matters: Google DeepMind's shift from a research-centric entity to an AI product powerhouse is a significant development in the tech industry. This transition, reported in June, signifies a strategic pivot to commercial services, potentially disrupting traditional research paradigms.
为何重要：谷歌DeepMind从以研究为中心的实体向人工智能产品强国的转变是科技行业的重大发展。6月份公布的这一转变标志着战略转向商业服务，有可能颠覆传统的研究模式。
In May, Google DeepMind introduced AlphaFold 3, an AI model capable of predicting the structure and interactions of biological molecules, including proteins and DNA. This model is available for non-commercial use, aiding scientists in disease research.
5月，谷歌DeepMind推出了AlphaFold 3，这是一款能够预测包括蛋白质和DNA在内的生物分子的结构和相互作用的人工智能模型。该模型可用于非商业用途，可帮助科学家进行疾病研究。
On the other hand, BioNTech has faced financial challenges, reporting deeper losses in Q2 2024 due to reduced demand for its COVID-19 vaccine. The company has increased R&D spending on new cancer treatments, highlighting the importance of innovative solutions like AI to drive future growth.
另一方面，BioNTech面临财务挑战，报告称，由于对其 COVID-19 疫苗的需求减少，2024年第二季度亏损更大。该公司增加了新癌症疗法的研发支出，凸显了人工智能等创新解决方案对推动未来增长的重要性。
Price Action: As per Benzinga Pro, GOOGL closed at $166.99 while GOOG ended at $168.42. BioNTech closed at $119.93.
价格走势：根据Benzinga Pro的数据，谷歌收于166.99美元，而GOOG收于168.42美元。BioNTech收于119.93美元。
- CVS Health in Focus as Activist Investor Prepares for High-Level Talks
- 激进投资者为高级别会谈做准备之际，CVS 健康备受关注
Image via Shutterstock
图片来自 Shutterstock
This story was generated using Benzinga Neuro and edited by Pooja Rajkumari
这个故事是使用 Benzinga Neuro 创作的，由 Pooja Rajkumari
